Taltz and Dysplasia - a phase IV clinical study of FDA data

Summary:

Dysplasia is reported only by a few people who take Taltz.

The phase IV clinical study analyzes which people take Taltz and have Dysplasia. It is created by eHealthMe based on reports of 26,146 people who have side effects while taking Taltz from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 21, 2023

26,146 people reported to have side effects when taking Taltz.
Among them, 2 people (0.01%) have Dysplasia.

What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 26,173 Taltz users for its effectiveness, alternative drugs and more.

What is Dysplasia?

Dysplasia (enlargement of an organ or tissue) is found to be associated with 644 drugs and 315 conditions by eHealthMe.

Number of Taltz and Dysplasia reports submitted per year:

Age of people who have Dysplasia when taking Taltz *:

Common side effects people have besides Dysplasia *:

Psoriasis (immune-mediated disease that affects the skin): 1 person, 50.00%
Lipid Metabolism Disorder (genetic disorders are caused by errors in fatty acid metabolism): 1 person, 50.00%
Gastrointestinal Carcinoma (cancer of stomach or intestine): 1 person, 50.00%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 1 person, 50.00%

Common conditions people have *:

Psoriasis (immune-mediated disease that affects the skin): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Taltz and have Dysplasia?

Check whether Dysplasia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Dysplasia and when was it recovered:

Dysplasia in Taltz

Expand to all the drugs that have ingredients of ixekizumab:

Dysplasia and drugs with ingredients of ixekizumab

Alternative drugs to, pros and cons of Taltz:

Taltz (26,173 reports)

Common Taltz side effects:

Drug ineffective: 1,747 reports
Psoriasis (immune-mediated disease that affects the skin): 1,728 reports
Rashes (redness): 725 reports
Itching: 597 reports
Diarrhea: 532 reports
Joint pain: 527 reports

Browse all side effects of Taltz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Dysplasia treatments and more:

Dysplasia (1,387 reports)

COVID vaccines that are related to Dysplasia:

Common drugs associated with Dysplasia:

Humira: 120 reports

All the drugs that are associated with Dysplasia:

Dysplasia (644 drugs)

All the conditions that are associated with Dysplasia:

Dysplasia (315 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ixekizumab (the active ingredients of Taltz) and Taltz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.